European freeze-drying market heats up: Symbiosis invests citing high demand
Symbiosis Pharmaceutical Services has launched a bulk freeze drying offering for APIs and intermediates, citing new contracts as a driver for the investment.
Archives for May 18, 2015
Strike while the ion is hot: Metrion targets demand for cardiac risk testing
Making sure candidate drugs are free of cardiac risks means drug industry demand for ion channel screening expertise is growing according to new CRO, Metrion.
Endo buys Par, Lupin enters Brazil... it's been a busy week in generics
Endo’s $8bn takeover of Par Pharmaceutical is expected to shake-up the generics sector, while Lupin is expanding its South American network – welcome to In-Pharmatechnologist’s M&A round-up.
Bioquell mulls sale citing investor interest in pharma and worries resistance worries as growth opportunities
Bioquell has launched a strategic review of its contamination control technology business which could result in a sale of the company.
Cancer-hunting shark proteins are the future of drug conjugation, says Almac
Almac is coupling tiny shark proteins to a cancer-killing warhead to develop an oncology drug, saying their small size makes for easy conjugation.